Cadrenal Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2 | $0 |
Gross Profit | 2 | |||
EBITDA | -2,466 | -1,755 | -1,263 | -1,035 |
EBIT | -2,466 | -1,755 | -1,263 | -1,036 |
Net Income | -2,392 | -1,663 | -1,144 | -1,036 |
Net Change In Cash | 0 | 0 | 2 | 0 |
Free Cash Flow | -1,529 | -1,836 | -697 | -627 |
Cash | 5,037 | 6,566 | 8,402 | 9,109 |
Basic Shares | 1,067 | 1,070 | 868 | 868 |
Annual Financials
| Values in thousands | 2023-12-31 |
|---|---|
Revenue | $0 |
Gross Profit | -1 |
EBITDA | -7,630 |
EBIT | -7,632 |
Net Income | -8,357 |
Net Change In Cash | 0 |
Free Cash Flow | -3,533 |
Cash | 8,402 |
Basic Shares | 868 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$2.25 |
2024-03-31 | -$0.10 |
2023-12-31 | -$0.05 |
2023-09-30 | -$0.07 |
